Logo
x

Search category

Subscribe Now

Biogen

Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New SPINRAZA (nusinersen) Long-Term Data in SMA

Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New SPINRAZA (nusinersen) Long-Term Data i...

  • August 7, 2023
Biogen and Sage Therapeutics’ Zurzuvae (zuranolone) Receive the US FDA’s Approval for Women with Postpartum Depression

Biogen and Sage Therapeutics’ Zurzuvae (zuranolone) Receive the US FDA’s Approval for Women with Postpartum Depression

  • August 7, 2023
PharmaShots Weekly Snapshots (July 31 – August 04, 2023)

PharmaShots Weekly Snapshots (July 31 – August 04, 2023)

  • August 4, 2023
Biogen to Acquire Reata Pharmaceuticals for ~$7.3B

Biogen to Acquire Reata Pharmaceuticals for ~$7.3B

  • July 31, 2023
Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New Data Published about SPINRAZA

Kathleen Somera-Molina, Head of SMA Global Medical Affairs at Biogen Shares Insights on New Data Published about SPINRAZA

  • July 25, 2023
Dr. Mourad Farouk Rezk, Head of Global Medical & Development Biogen Biosimilars Shares Insights on BLA Acceptance for BIIB800

Dr. Mourad Farouk Rezk, Head of Global Medical & Development Biogen Biosimilars Shares Insights on BLA Acceptance for BIIB800

  • July 11, 2023
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2023 PharmaShots - All Rights Reserved.